A frequently reported and often welcome experience for individuals using these medications is a significant reduction in "food noise"
Heres how your clinic can leverage telemedicine to expand weight loss services efficiently
Clinical Trial Status: Where Each Compound Stands in 2026 Tirzepatide (Fully Approved) Tirzepatide completed its regulatory journey and received: FDA approval as Mounjaro (2022) for type 2 diabetes management FDA approval as Zepbound (2023) for chronic weight management in adults with obesity or overweight with weight-related comorbidities It is available via prescription from licensed healthcare providers in the United States and many other countries
CATEGORY STRUCTURE, SEGMENTATION AND PRODUCT MATRIX How the Market Splits Into Decision-Relevant Buckets By Product Type / Configuration By Application / End Use By Customer / Buyer Type By Channel / Business Model / Technology Platform Segment Attractiveness Matrix Product Matrix and Segment Growth Logic 6
Expanding Applications: Clinical trials are actively investigating the use of GLP-1 RAs for a wider range of conditions, including addiction, kidney disease, and neurodegenerative disorders, based on their broad physiological effects
The European Medicines Agencys (EMA) Pharmacovigilance Risk Assessment Committee concluded that no product label update was warranted, based on data from clinical trials, real-world safety monitoring, and electronic health records [45]
